RE:RE:RE:RE:RE:RE:RE:RE:RE:Of all analysts DOWNGRADES, Raymond James got it rightThat's possible. my understanding is that the comment about gaining market share as a result of the rotech deal was probably due to regulatory or market share issues with the two companies combining...i.e. some patients or jurisdictions would have to be given up.
More curious about why they have 135 locations listed on new deck and latest PR, while all previous ones had 125...did they do a deal?